Claybrook Capital’s Crescent Capital BDC CCAP Stock Holding History

Claybrook Capital’s Portfolio CCAP Stock Details CCAP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$239K	Hold	13,975	–	–	0.14%	121
2023 Q2	$212K	Hold	13,975	–	–	0.11%	129
2023 Q1	$190K	Buy	+13,975	New	+$202K	0.11%	133

Other funds holding CCAP

Texas County & District Retirement System Austin, Texas $60.8M AUM 29.03% 1-Year Est. Return

Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return

Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Relative Value Partners Group $772M AUM 15.6% 1-Year Est. Return

Aspen Grove Capital Avon, Colorado $514M AUM 21.8% 1-Year Est. Return

Claybrook Capital's CCAP Position: Q3 2023 in Review

Claybrook Capital held its Crescent Capital BDC (CCAP) position steady in Q3 2023 at 13,975 shares worth $239K. The position accounts for 0.14% of the portfolio, ranked #121.

Claybrook Capital first reported a position in CCAP in Q1 2023 and has held it in 3 quarters since. 70 funds tracked by Wall St. Rank hold CCAP as of Q3 2023.

Claybrook Capital held 13,975 shares of Crescent Capital BDC worth $239K as of Q3 2023.
Claybrook Capital left its Crescent Capital BDC share count unchanged in Q3 2023.
Crescent Capital BDC made up 0.14% of Claybrook Capital's portfolio in Q3 2023, its #121 holding.
Claybrook Capital first reported a position in Crescent Capital BDC in Q1 2023 and has held it in 3 quarters since.
70 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q3 2023.

Based on Claybrook Capital's 13F filing for Q3 2023, filed 24 Oct 2023.